Novartis Sandoz Unveils Plan For China Production And Distribution Center
This article was originally published in PharmAsia News
Executive Summary
Novartis Sandoz recently disclosed plans to make its Zhongshan company the China pharmaceutical production base, and will move its current sales center to the city to establish Sandoz China production and distribution center. Set up in Zhongshan in 2007, Novartis Sandoz focuses on pharmaceutical chemicals, capsules, tablets and repackaging of imported medicines. The company's revenue saw more than $40 million in 2008 with its production of eight main types of medicines. Novartis has identified China as the growth engine for its global expansion and top-level corporate executives will visit relevant Chinese government officials by the end of this month. (Click here for more - Chinese Language)